和田 啓道

Importance of non-cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction. 

ESC heart failure 12(1) 389-400 2025年2月  

Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan. 

European heart journal open 4(1) oead135 2024年1月  

Proteinuria is independently associated with heart failure events in patients with atrial fibrillation: The Fushimi AF registry. 

European heart journal. Quality of care & clinical outcomes 2023年1月5日  

Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan (YiganSan), in smokers with depressive tendencies 

BMC Complementary Medicine and Therapies 22(1) 2022年11月25日  

Machine Learning Risk Prediction for Incident Heart Failure in Patients With Atrial Fibrillation. 

JACC. Asia 2(6) 706-716 2022年11月  

Ameliorating prediabetic subject status via fermented tea supplementation: A randomized, double-blind, parallel-group comparison study 

Journal of Functional Foods 97 105257-105257 2022年10月  

Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study. 

European heart journal open 2(5) oeac057 2022年9月  

Association of Concomitant Coronary Artery Disease With Cardiovascular Events in Patients With Atrial Fibrillation - The Fushimi AF Registry. 

Circulation journal : official journal of the Japanese Circulation Society 86(8) 1252-1262 2022年7月25日  

Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial. 

JMIR research protocols 11(7) e38626 2022年7月7日  

Higher Serum Soluble TREM2 as a Potential Indicative Biomarker for Cognitive Impairment in Inadequately Controlled Type 2 Diabetes Without Obesity: The DOR-KyotoJ-1 

Frontiers in Endocrinology 13 2022年5月3日  

10-Year Trends of Antithrombotic Therapy Status and Outcomes in Japanese Atrial Fibrillation Patients - The Fushimi AF Registry. 

Circulation journal : official journal of the Japanese Circulation Society 86(4) 726-736 2022年3月25日  

VA-ECMOからの離脱成功のリスクスコア 国立病院機構の多施設共同コホート研究(Risk Score of Successful Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation: National Hospital Organization Multicenter Cohort Study) 

日本循環器学会学術集会抄録集 86回 JO03-8 2022年3月  

Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study. 

Journal of the American Heart Association 11(3) e023464 2022年2月  

The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2-GATA4 Signaling Pathway. 

Pharmaceuticals (Basel, Switzerland) 14(12) 2021年12月5日  

Clinical Characteristics and Outcomes of Very Elderly Patients With Atrial Fibrillation at High Bleeding Risk - The Fushimi AF Registry. 

Circulation reports 3(11) 629-638 2021年11月10日  

Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry. 

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 23(9) 1369-1379 2021年9月8日  

Major adverse cardiovascular events and mortality after catheter ablation in Japanese patients with atrial fibrillation: The Fushimi AF Registry. 

Heart and vessels 36(8) 1219-1227 2021年8月